Cost-effectiveness of raising HDL cholesterol by adding prolonged-release nicotinic acid to statin therapy in the secondary prevention setting: a French perspective
S. Roze, J. Ferrières, E. Bruckert, E. Van Ganse, M. J. Chapman, D. Liens, C. RenaudinVolume:
61
Year:
2007
Language:
english
Pages:
7
DOI:
10.1111/j.1742-1241.2007.01546..x
File:
PDF, 218 KB
english, 2007